Ruboxistaurin mesylate

DRUG3 trials

Sponsors

Eli Lilly and Company, Chromaderm, Inc.

Conditions

Diabetes MellitusDiabetes Mellitus, Insulin-DependentDiabetes Mellitus, Non-Insulin-DependentDiabetic Neuropathies

Phase 3

Treatment for Symptomatic Peripheral Neuropathy in Patients With Diabetes

CompletedNCT00044408

Chromaderm, Inc.Diabetes Mellitus, Insulin-Dependent, Diabetes Mellitus, Non-Insulin-Dependent, Diabetic Neuropathies

Start: 2002-07-31End: 2005-10-31Target: 200Updated: 2016-07-26

Treatment for Symptomatic Peripheral Neuropathy in Patients With Diabetes

CompletedNCT00044395

Eli Lilly and CompanyDiabetes Mellitus, Insulin-Dependent, Diabetes Mellitus, Non-Insulin-Dependent, Diabetic Neuropathies

Start: 2002-07-31End: 2005-10-31Target: 200Updated: 2007-11-06

Treatment of Peripheral Neuropathy in Patients With Diabetes

CompletedNCT00044421

Eli Lilly and CompanyDiabetes Mellitus, Diabetic Neuropathies

Start: 2002-07-31End: 2006-10-31Target: 400Updated: 2007-11-06

Related Papers

How many unpublished studies? ClinicalTrials.gov (n = 2614 studies): diabetes | Closed Studies | Interventional Studies | Phase 3, 4 | Search Date: Oct 27, 2014

Figshare2014-01-01